2023
DOI: 10.1016/j.tox.2023.153654
|View full text |Cite
|
Sign up to set email alerts
|

Lead exposure induces neuronal apoptosis via NFκB p65/RBBP4/Survivin signaling pathway

Hui Chen,
Wei Zhang,
Song Luo
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…In the realm of targeted therapy research focused on RBBP4/7, these proteins have demonstrated significant potential in the treatment of various diseases, particularly in modulating therapeutic outcomes. For example, increased expression of RBBP4 has been linked to mitigating lead-induced neuronal apoptosis, suggesting a potential role in alleviating lead poisoning and related neurological disorders ( 178 ). Additionally, the interaction of RBBP4 with the efficacy of multiple drugs has been extensively studied, including its role in enhancing the sensitivity of GBM cells to TMZ ( 56 , 95 ), suppression of LC cell malignancy via ropivacaine by downregulating RBBP4 ( 179 ), and the identification of the circ-0110498/miR-1287-5p/RBBP4 axis as a novel target for overcoming cisplatin resistance in NSCLC ( 85 ).…”
Section: Rbbp4/7 As Potential Targets For Human Disease Treatmentmentioning
confidence: 99%
“…In the realm of targeted therapy research focused on RBBP4/7, these proteins have demonstrated significant potential in the treatment of various diseases, particularly in modulating therapeutic outcomes. For example, increased expression of RBBP4 has been linked to mitigating lead-induced neuronal apoptosis, suggesting a potential role in alleviating lead poisoning and related neurological disorders ( 178 ). Additionally, the interaction of RBBP4 with the efficacy of multiple drugs has been extensively studied, including its role in enhancing the sensitivity of GBM cells to TMZ ( 56 , 95 ), suppression of LC cell malignancy via ropivacaine by downregulating RBBP4 ( 179 ), and the identification of the circ-0110498/miR-1287-5p/RBBP4 axis as a novel target for overcoming cisplatin resistance in NSCLC ( 85 ).…”
Section: Rbbp4/7 As Potential Targets For Human Disease Treatmentmentioning
confidence: 99%